Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck - Bastholt, Lars; Specht, Lena; Jensen, Kenneth; Brun, Eva; Loft, Annika; Petersen, Jørgen; Kastberg, Helle; Eriksen, Jesper G. (Radiotherapy & Oncology, 2007)